Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction

Circulation

Volumn 89, Issue 4, 1994, Pages 1573-1579

  Omland, Torbjørn ^a,c   Lie, Rolv Terje ^b   Aakvaag, Asbjørn ^c   Aarsland, Torbjørn ^d   Dickstein, Kenneth ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Hjertelaget Research Foundation   (Norway)

Author keywords

endothelin; heart failure; myocardial infarction; prognosis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ENDOTHELIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOTOXICITY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; VASOCONSTRICTION;

EID: 0028204079     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.4.1573     Document Type: Article

References (44)

1. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol. 1991;18:38-43.
2. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischaemic syndromes. Br Heart J. 1992;67:383-386.
3. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990;119:801-806.
4. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1989;2:53-54. Letter.
5. Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH. Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet. 1989;2:747. Letter.
6. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
7. Rodeheffer JE, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc. 1992;67:719-724.
8. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J. 1993;125:667-672.
9. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
10. Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal and endocrine actions of endothelin. J Clin Invest. 1989;83:317-320.
11. Lerman A, Hildebrand FL Jr, Margulies KB, O'Murchu B, Perrella MA, Heublein DM, Schwab TR, Burnett JC Jr. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc. 1990;65:1441-1455.
12. Terashita Z, Shibouta Y, Imura Y, Iwasaki K, Nishikawa K. Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF). Life Sci. 1989;45:1911-1918.
13. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med. 1992;327:678-684.
14. Omland T, Barvik S, Aakvaag A, Aarsland T, Dickstein K. Plasma atrial natriuretic factor concentration during maximal cardiopulmonary exercise in men with mild heart failure. Int J Cardiol. 1990;29:179-184.
15. Hopkins A. Survival analysis with covariates. In: Dixon WJ, ed. BMDP Statistical Software Manual. Berkeley, Calif: University of California Press; 1990:769-806.
16. Benedetti J, Yuen K, Young L. Life tables and survivor functions. In: Dixon WJ, ed. BMDP Statistical Software Manual. Berkeley, Calif: University of California Press; 1990:739-768.
17. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun. 1989;161:562-567.
18. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
19. Merrilees MA, Scott PJ, Norris RM. Prognosis after myocardial infarction: results of 15 years follow up. Br Med J. 1984;288:356-359.
20. Svanegaard J, Angelo-Nielsen K, Pindborg T. Plasma concentrations of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J. 1992;68:38-42.
21. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol. 1993;72:255-259.
22. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:1534-1539.
23. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
24. Velasco CE, Jackson EK, Morrow JA, Vitola JV, Inagami T, Forman MB. Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion. Cardiovasc Res. 1993;27:121-128.
25. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Cire Res. 1991;69:370-377.
26. Lerman A, Heublein DM, Burnett JC Jr, Rodeheffer RJ. Congestive heart failure is characterized by systemic endothelin activation. J Am Coll Cardiol. 1993;21:315A. Abstract.
27. Emori T, Hirata Y, Ohta K, Schichiri M, Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1989;160:93-100.
28. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991;18:165-170.
29. Pernow J, Hemsén A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun. 1989;161:647-653.
30. De Nucci G, Thomas R, D'Orleans-Juste P, Antuñes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
31. Wagner OF, Vierhapper H, Gasic S, Nowotny P, Waldhäusl W. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur J Clin Invest. 1992;22:277-282.
32. Raine AEG, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986;315:533-537.
33. Tsutamoto T, Bito K, Kinoshita M. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. Am Heart J. 1989;117:599-606.
34. Tomoda H. Atrial natriuretic peptide in acute myocardial infarction. Am J Cardiol. 1988;62:1122-1123.
35. Krämer BK, Nishida M, Kelly RA, Smith TW. Endothelins: myocardial actions of a new class of cytokines. Circulation. 1992;85:350-356.
36. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentrations. Circulation. 1991;83:1808-1814.
37. Donckier JE, Hanet C, Berbinschi A, Galanti L, Roberts A, Van Mechelen H, Pouleur H, Ketelslegers JM. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation. 1991;84:2476-2484.
38. Vierhapper H, Wagner O, Nowotny P, Waldhäusl W. Effect of endothelin-1 in man. Circulation. 1990;81:1415-1418.
39. Salvati P, Chierchia S, Dho L, Ferrario RG, Parenti P, Vicedomini G, Patrono C. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow. J Cardiovasc Pharmacol. 1991;17:1007-1014.
40. Yorikane R, Shiga H, Miyake S, Koike H. Evidence for direct arrhythmogenic action of endothelin. Biochem Biophys Res Commun. 1990;173:457-462.
41. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J. 1993;307:349-353.
42. Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders; 1992:1200-1201.
43. Hillis LD, Forman S, Braunwald E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 1990;16:313-315.
44. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.